* Background: Serrated polyposis syndrome is the most common colorectal polyposis syndrome. Its pathogenesis is still unknown and its diagnosis is based on clinical criteria. Despite advances in its knowledge, the intestinal microbiota of these patients has not been characterized, nor has the role of Fusobacterium nucleatum in their lesions been evaluated. * Aim: The main objective is to compare the composition of the intestinal and oral microbiota of individuals diagnosed with serrated polyposis syndrome with individuals with sporadic serrated polyps, adenomatous polyps and without polyps. Among the secondary objective is to establish the prevalence of Fusobacterium nucleatum in oral and fecal samples. * Methodology: Observational, case-control and multicenter study. Prospective inclusion for 24 months of all patients diagnosed with serrated polyposis syndrome, associated with three control groups: individuals without polyps, individuals with sporadic serrated lesions and individuals with adenomas. Clinical, histological, and endoscopic data will be recorded, and biological samples from saliva, and feces will be collected.
Study Type
OBSERVATIONAL
Enrollment
126
Lara Aguilera Castro
Barcelona, Barcelona, Spain
Characterization of Intestinal Microbiota through 16S Sequencing
Characterization of Intestinal Microbiota through 16S Sequencing
Time frame: 1 year
Characterization of Oral Microbiota through 16S Sequencing
Characterization of Oral Microbiota through 16S Sequencing
Time frame: 1 year
Quantitative Polymerase Chain Reaction (qPCR) from F. nucleatum.
Quantitative Polymerase Chain Reaction (qPCR) from F. nucleatum in saliva and feces.
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.